Follow Us

Some offspring of Moderna mRNA vaccine test rats born with skeletal deformities: Judicial Watch

An advisory committee for the FDA voted in June to recommend that children as young as 6 months old receive the Moderna COVID-19 vaccine.

Published: December 13, 2022 5:10pm

Updated: December 13, 2022 5:44pm

Pharmaceutical company Moderna informed the Food and Drug Administration that a "statistically significant" number of rats whose mothers received the company's mRNA COVID-19 vaccine were born with skeletal deformities, according to data from the Department of Health and Human Services that a watchdog group obtained.

Judicial Watch announced on Tuesday that HHS had handed over 699 pages of records pertaining to data Moderna sent the FDA. Said handover followed a Freedom of Information Act lawsuit the group filed to obtain the records after the relevant agencies failed to respond to the initial FOIA request.

A "nonclinical overview" included in the records the group obtained noted that "mRNA-1273 [Moderna vaccine]-related variations in skeletal examination included statistically significant increases in the number of F1 rats with 1 or more wavy ribs and 1 or more rib nodules. Wavy ribs appeared in 6 fetuses and 4 litters with a fetal prevalence of 4.03% and a litter prevalence of 18.2%. Rib nodules appeared in 5 of those 6 fetuses."

"Skeletal variations are structural changes that do not impact development or function of a developing embryo, are considered reversible, and often correlate with maternal toxicity and/or lack of other indicators of developmental toxicity (Carney and Kimmel 2007)," it continued. "Maternal toxicity in the form of clinical observations was observed for 5 days following the last dose (GD 13), correlating with the most sensitive period for rib development in rats (GDs 14 to 17)."

"Furthermore, there were no other indicators of mRNA-1273-related developmental toxicity observed, including delayed ossification; therefore, these common skeletal variations were not considered adverse," the records read.

The watchdog then contrasted the overview's dismissal of the abnormalities as non "adverse" with a separate article espousing that a comparable abnormality "may give rise to a different and more severe outcome."

An advisory committee for the FDA voted in June to recommend that children as young as 6 months old receive the Moderna COVID-19 vaccine.

The Moderna vaccine received full FDA approval on Jan. 31 of this year. It was previously available under an emergency use authorization.

The Facts Inside Our Reporter's Notebook

Just the News Spotlight